Literature DB >> 12591724

The carcinogen (7R,8S)-dihydroxy-(9S,10R)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene induces Cdc25B expression in human bronchial and lung cancer cells.

Tetsuya Oguri1, Shivendra V Singh, Kaoru Nemoto, John S Lazo.   

Abstract

Cdc25B regulates cell cycle progression and genetic stability. Here, we report that exposure to the environmental carcinogen (7R,8S)-dihydroxy-(9S,10R)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (anti-BPDE) causes a marked increase in the expression of Cdc25B mRNA and protein levels in terminal squamous differentiated human bronchial epithelial cells and in lung cancer cells, but not in undifferentiated bronchial cells. In addition, the growth rate of lung cancer cells was increased significantly in comparison with untreated cells after chronic exposure to 0.1 micro M anti-BPDE. Furthermore, increased Cdc25B expression and decreased Cdk1 phosphorylation were observed in anti-BPDE-treated cells. We postulate that the induction of Cdc25B expression in lung cancer cells by the ultimate carcinogen anti-BPDE accelerates the further development of lung carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12591724

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  1 in total

1.  Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases.

Authors:  Shugeng Cao; Brian T Murphy; Caleb Foster; John S Lazo; David G I Kingston
Journal:  Bioorg Med Chem       Date:  2008-11-08       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.